David Loew
Chief Executive Officer bei IPSEN
Vermögen: 59 562 $ am 31.03.2024
Profil
David G. Loew ist Chief Executive Officer & Director bei Ipsen SA und Chief Executive Officer bei Ipsen Pharma SAS (einer Tochtergesellschaft von Ipsen SA). In der Vergangenheit war er Executive Vice President-Sanofi Pasteur bei Sanofi und Global Head-Product Strategy bei Genentech, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IPSEN SA
0,00% | 31.12.2022 | 500 ( 0,00% ) | 59 562 $ | 31.03.2024 |
Aktive Positionen von David Loew
| Unternehmen | Position | Beginn |
|---|---|---|
| IPSEN | Chief Executive Officer | 01.07.2020 |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Chairman | 30.07.2020 |
| European Federation of Pharmaceutical Industries & Assoc | Director/Board Member | - |
| G5 Santé | Director/Board Member | - |
Ehemalige bekannte Positionen von David Loew
| Unternehmen | Position | Ende |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 15.06.2020 |
| GAVI Alliance | Director/Board Member | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Ausbildung von David Loew
| University of St. Gallen | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| SANOFI | Health Technology |
| IPSEN | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| GAVI Alliance | Miscellaneous |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
| European Federation of Pharmaceutical Industries & Assoc | |
| G5 Santé |
